UnissResearch

Logo Universitàegli studi di Sassari
titoli, abstracts, parole chiave >>>
Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages?

Miolo, GianMaria and Bidoli, Ettore and Lombardi, Davide and Santeufemia, Davide Adriano and Capobianco, Giampiero and Dessole, Francesco and Scalone, Simona and Spazzapan, Simon and Sorio, Roberto and Tabaro, Gianna and Veronesi, Andrea (2012) Weekly paclitaxel in heavily pretreated ovarian cancer patients: does this treatment still provide further advantages? Archives of Gynecology and Obstetrics, Vol. 285 (2), p. 499-503. eISSN 1432-0711. Article.

Full text not available from this repository.

DOI: 10.1007/s00404-011-1976-9

Abstract

Objective: To evaluate the disease control rate (DCR) in heavily pretreated and relapsed ovarian cancer patients re-challenged with a weekly paclitaxel schedule and to establish whether a correlation between dose intensity, progression-free interval (PFI) and overall survival (OS) exists.
Methods: Retrospective data were collected from 30 heavily pretreated metastatic ovarian cancer patients who received 80 mg/m(2)/week paclitaxel regimen.
Results: The treatment was well tolerated and showed a DCR in 70% of the patients, with only one case of grade 3 hematological toxicity. One patient (3%) showed a complete response, 15 patients (50%) a partial response and five patients (17%) a stabilization of their disease. The regimen was mostly used as a fourth-line chemotherapy (range 2-7). The median dose intensity in responding patients was 57.5 mg/m(2)/week and in those with progressive disease 49.7 mg/m(2)/week. (p = 0.20). PFI and OS were increased in the responder patient groups with a log-rank test of 25.64 (p < 0.001) and 15.10 (p = 0.0001), respectively.
Conclusions: Weekly administration of paclitaxel was active and well tolerated as a salvage therapy for heavily pretreated ovarian cancer patients.

Item Type:Article
ID Code:7717
Status:Published
Refereed:Yes
Uncontrolled Keywords:Chemotherapy, dose density, ovarian carcinoma, weekly paclitaxel
Subjects:Area 06 - Scienze mediche > MED/40 Ginecologia e ostetricia
Divisions:001 Università di Sassari > 01-a Nuovi Dipartimenti dal 2012 > Scienze Chirurgiche, Microchirurgiche e Mediche
Publisher:Springer
eISSN:1432-0711
Deposited On:21 Jun 2012 11:25

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page